The AGM of the Company for the financial year 31-03-2025 will be held on or before December 31, 2025, instead of the earlier due date of 30-09-2025. A copy of the approval letter received ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transgene Biotek Ltd has informed the stock exchange that the Registrar of Companies (ROC), Hyderabad has approved a 3-month extension for holding its Annual General Meeting for the financial year ended March 31, 2025. The AGM, originally due by September 30, 2025, will now be held on or before December 31, 2025. The company had applied for this extension on August 13, 2025, citing reasons accepted by the ROC under Section 96(1) of the Companies Act, 2013. The ROC has also cautioned the company to be careful about future compliance with AGM timelines. The communication was signed by Dr. K. Koteswara Rao, Chairman & Managing Director.
This is a procedural/administrative update and does not affect business operations or financials. However, the delayed AGM and the ROC's caution note may raise minor governance concerns among shareholders, as financial results and annual reports will also be deferred by up to three months.